We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Agilent to Be Exclusive Marketer of CyberLab

By Biotechdaily staff writers
Posted on 21 Jul 2004
An integrated portfolio of laboratory software known as CyberLab will now be sold exclusively by Agilent Technologies, Inc. More...
(Palo Alto, CA, USA), according to a recently announced agreement with Scientific Software Inc. (SSI, Pleasanton, CA, USA), which developed the system.

Used by laboratories, chemical companies, and pharmaceutical firms, the CyberLab Enterprise Content Management System (ECMS) is a web-based electronic library that collects, organizes, indexes, stores, archives, and shares electronic records. These include raw analytical instrument data and reports to compliance records; molecular drawings, pictures, and videos; MS Office documents; and PDF documents. CyberLab automatically extracts searchable data from each file and provides powerful search capabilities and embedded viewers for many file types. The system is designed to find information quickly and help users make more informed decisions. The company will market the product under its new family name, Agilent Cerity, to chemical, forensic, environmental, pharmaceutical, petrochemical, homeland security, and food markets.

"This will enable scientists to collaborate across laboratory operations, linking information from a wide range of analytical instrumentation and data sources,” said Jim Miller, director of software for Agilent's life sciences and chemical analysis business.

Under the agreement, Scientific Software maintains intellectual property rights to CyberLab ECMS and will continue to focus on new-product development as well as working with technology partners to develop integrations with enterprise applications such as LIMS (laboratory information management system) and other established vendors of analytical instrumentation.





Related Links:
Agilent
Scientific Software

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Pipette Calibration System
Artel PCS®
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.